Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionNvwm, Llc
Latest Disclosed Ownership20 shares
Latest Disclosed Value $ 3,055
Nvwm, Llc ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 27, 2026 - Nvwm, Llc filed a 13F-HR form disclosing ownership of 20 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $3,055 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 20 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,873 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 20 0 0.00 3 50.00 0.0004
2026-01-20 2025-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 20 0 0.00 3 0.00 0.0006
2025-10-16 2025-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 20 0 0.00 3 0.00 0.0006
2025-08-06 2025-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 20 20 2 0.0006
2023-05-11 2023-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -123 -100.00 0 -100.00
2023-02-14 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 123 123 11 0.0041
2022-08-04 2022-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -44 -100.00 0 -100.00
2022-05-11 2022-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 44 44 4 0.0013
2021-11-03 2021-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -49 -100.00 0 -100.00
2021-08-04 2021-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 49 0 0.00 4 0.00 0.0014
2021-05-11 2021-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 49 0 0.00 4 -20.00 0.0016
2021-02-09 2020-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 49 -6,010 -99.19 5 -99.05 0.0021
2020-12-10 2020-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,059 485 8.70 527 8.21 0.2474
2020-08-11 2020-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,574 194 3.61 487 9.93 0.2622
2020-05-08 2020-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 5,380 272 5.32 443 -8.47 0.3078
2020-02-07 2019-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 5,108 -52 -1.01 484 8.04 0.2899
2019-11-08 2019-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR ADR 66987V109 5,160 4,985 2,848.57 448 2,700.00 0.2753
2019-10-29 2019-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 5,160 4,985 448 0.2745
2019-08-07 2019-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 16 -5.88 0.0097
2019-05-10 2019-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 17 13.33 0.0113
2019-01-29 2018-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 15 0.00 0.0112
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 15 15.38 0.0095
2018-08-01 2018-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 13 -7.14 0.0090
2018-05-17 2018-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 0 0.00 14 -6.67 0.0102
2018-03-15 2017-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 175 175 15 0.0114
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.